GOSS News

Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Placebo Response Risks: SueWallSt

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOSS

Class Action Lawsuit Reminder from Pomerantz LLP for Investors of Gossamer Bio, Inc. – GOSS

Robbins LLP Reminds GOSS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Gossamer Bio, Inc.

DEADLINE ALERT: zSpace (ZSPC) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 22, 2026 Securities Class Action Deadline Ready to Announce with Confidence?

DEADLINE ALERT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline Ready to Announce with Confidence?